Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity.
暂无分享,去创建一个
R. Schinazi | G. R. Revankar | J. Imbach | J. Sommadossi | R. Rando | G. Gosselin | L. Cui | J. Sommadossi | C. K. Chu | Chung K. Chu | Robert F. Rando
[1] J. Ojwang,et al. Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidine , 1995, Antimicrobial agents and chemotherapy.
[2] M. Swartz. Mitochondrial toxicity--new adverse drug effects. , 1995, The New England journal of medicine.
[3] J. Ojwang,et al. Synthesis and anti-DNA viral activities in vitro of certain 2,4-disubstituted-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)pyrrolo[2,3-d d pyrimidine nucleosides. , 1995, Journal of medicinal chemistry.
[4] V. Nair,et al. Antiviral activities of isometric dideoxynucleosides of D- and L-related stereochemistry , 1995, Antimicrobial agents and chemotherapy.
[5] R. Schinazi,et al. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells. , 1995, The Journal of clinical investigation.
[6] C. Tsai,et al. Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production. , 1994, Biochemical pharmacology.
[7] J. Colacino,et al. Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture , 1994, Antimicrobial Agents and Chemotherapy.
[8] R. Schinazi,et al. Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro , 1994, Antimicrobial Agents and Chemotherapy.
[9] R. Schinazi,et al. Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro , 1994, Antimicrobial Agents and Chemotherapy.
[10] J. Sommadossi,et al. Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis , 1994, Antimicrobial Agents and Chemotherapy.
[11] G. Dutschman,et al. Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro , 1994 .
[12] V. Skalski,et al. The biochemical basis for the differential anti-human immunodeficiency virus activity of two cis enantiomers of 2',3'-dideoxy-3'-thiacytidine. , 1993, The Journal of biological chemistry.
[13] R. Schinazi,et al. Structure-activity relationships of beta-D-(2S,5R)- and alpha-D-(2S,5S)-1,3-oxathiolanyl nucleosides as potential anti-HIV agents. , 1993, Journal of medicinal chemistry.
[14] J. Sommadossi. Nucleoside analogs: similarities and differences. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] R. Schinazi,et al. Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents. , 1993, Journal of medicinal chemistry.
[16] R. Schinazi,et al. 1,3-dioxolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytes. , 1993, Journal of medicinal chemistry.
[17] L W Frick,et al. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine , 1992, Antimicrobial Agents and Chemotherapy.
[18] R. Schinazi,et al. Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2',3'-dideoxy-3'-thiacytidine in normal human bone marrow progenitor cells. , 1992, Biochemical pharmacology.
[19] R F Schinazi,et al. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine , 1992, Antimicrobial Agents and Chemotherapy.
[20] G. Maga,et al. L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. , 1992, Journal of medicinal chemistry.
[21] R. Schinazi,et al. Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication. , 1992, The Journal of biological chemistry.
[22] William,et al. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. , 1992, The Journal of clinical investigation.
[23] R. Schinazi,et al. Synthesis of enantiomerically pure (2'R,5'S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV) , 1992 .
[24] R. Schinazi,et al. Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes , 1992, Antimicrobial Agents and Chemotherapy.
[25] C. H. Chen,et al. The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2',3'-dideoxycytidine. , 1992, The Journal of biological chemistry.
[26] R. Schinazi,et al. Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. H. Chen,et al. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. , 1991, Molecular pharmacology.
[28] S. Dimauro,et al. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy , 1991, The Lancet.
[29] M. Dalakas,et al. Mitochondrial myopathy caused by long-term zidovudine therapy. , 1990, The New England journal of medicine.
[30] C. H. Chen,et al. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. , 1989, The Journal of biological chemistry.
[31] F. Sanger,et al. Sequence and organization of the human mitochondrial genome , 1981, Nature.
[32] T. S. Rao,et al. Total synthesis of 2′-deoxy-2′-arafluoro-tubercidin, -toyocamycin, -sangivamycin and certain related nucleosides , 1995 .
[33] R. Schinazi,et al. Enantiomeric 2',3'-dideoxycytidine derivatives are potent human immunodeficiency virus inhibitors in cell cultures. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[34] D. Wallace,et al. Diseases of the mitochondrial DNA. , 1992, Annual review of biochemistry.